BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8749657)

  • 1. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium.
    Chia JK; Nakata MM; Park SS; Lewis RP; McKee B
    Clin Infect Dis; 1995 Dec; 21(6):1520. PubMed ID: 8749657
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium.
    Mondy KE; Shannon W; Mundy LM
    Clin Infect Dis; 2001 Aug; 33(4):473-6. PubMed ID: 11462182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium.
    Weinstein MR; Dedier H; Brunton J; Campbell I; Conly JM
    Clin Infect Dis; 1999 Aug; 29(2):361-6. PubMed ID: 10476743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant Enterococcus faecium meningitis successfully treated with chloramphenicol.
    Pérez Mato S; Robinson S; Bégué RE
    Pediatr Infect Dis J; 1999 May; 18(5):483-4. PubMed ID: 10353532
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
    Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
    Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
    [No Abstract]   [Full Text] [Related]  

  • 6. Vancomycin-resistant Enterococcus faecium shunt infection in an infant: an antibiotic cure.
    Nachman SA; Verma R; Egnor M
    Microb Drug Resist; 1995; 1(1):95-6. PubMed ID: 9156389
    [No Abstract]   [Full Text] [Related]  

  • 7. Vancomycin-resistant enterococci on a renal ward in an Ontario hospital.
    Lior L; Litt M; Hockin J; Kennedy C; Jolley BA; Garcia M; Gillis G; Humar A; Campbell I; Brunton J; Dedier H; Conly J
    Can Commun Dis Rep; 1996 Aug; 22(15):125-8. PubMed ID: 8791860
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment options for chronic prostatitis due to vancomycin-resistant Enterococcus faecium.
    Taylor SE; Paterson DL; Yu VL
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):798-800. PubMed ID: 9923524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal acquisition of vanD gene during vancomycin treatment of septicaemia caused by Enterococcus faecium.
    Starlander G; Tellgren-Roth C; Melhus Å
    J Hosp Infect; 2016 Apr; 92(4):409-10. PubMed ID: 26876745
    [No Abstract]   [Full Text] [Related]  

  • 10. First documented isolation of vancomycin-resistant Enterococcus faecium in Sweden.
    Melhus A; Tjernberg I
    Scand J Infect Dis; 1996; 28(2):191-3. PubMed ID: 8792490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species.
    Cormican MG; Johnson DM; Jones RN
    Diagn Microbiol Infect Dis; 1996 Jan; 24(1):59-60. PubMed ID: 8988766
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years.
    Roghmann MC; Qaiyumi S; Johnson JA; Schwalbe R; Morris JG
    Clin Infect Dis; 1997 Mar; 24(3):514-5. PubMed ID: 9114211
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vancomycin-resistant enterococci . Work Group Hospital Infection Epidemiology].
    Endtz HP; van Belkum A; van Duin J
    Ned Tijdschr Geneeskd; 1997 Jan; 141(2):108-9. PubMed ID: 9036340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
    Gonzales RD; Schreckenberger PC; Graham MB; Kelkar S; DenBesten K; Quinn JP
    Lancet; 2001 Apr; 357(9263):1179. PubMed ID: 11323048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci.
    Kirk M; Hill RL; Casewell MW; Beighton D
    Adv Exp Med Biol; 1997; 418():483-5. PubMed ID: 9331699
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns.
    Furlong WB; Rakowski TA
    Clin Infect Dis; 1997 Jul; 25(1):163-4. PubMed ID: 9243059
    [No Abstract]   [Full Text] [Related]  

  • 17. Vancomycin-resistant Enterococcus faecium meningitis successfully treated with linezolid.
    Mizell KN; Carter JE
    South Med J; 2008 May; 101(5):569-70. PubMed ID: 18458638
    [No Abstract]   [Full Text] [Related]  

  • 18. Vancomycin-resistant Enterococcus faecium ST17 outbreak in a Neonatal Unit.
    López-Urrutia L; de Frutos M; Oteo J; Eiros JM
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Mar; 36(3):198-200. PubMed ID: 28807390
    [No Abstract]   [Full Text] [Related]  

  • 19. Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia.
    Chow JW; Donahedian SM; Zervos MJ
    Clin Infect Dis; 1997 Jan; 24(1):90-1. PubMed ID: 8994759
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.
    Linden PK; Pasculle AW; Manez R; Kramer DJ; Fung JJ; Pinna AD; Kusne S
    Clin Infect Dis; 1996 Apr; 22(4):663-70. PubMed ID: 8729206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.